FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010414831> ?p ?o ?g. }

• W2010414831 endingPage "100" @default.
• W2010414831 startingPage "84" @default.
• W2010414831 abstract "We report the results of phosphoproteomic analysis of mouse thymoma cells treated with tributyltin oxide (TBTO), an immunotoxic compound. After cell lysis, phosphoproteins were isolated using Phosphoprotein Purification Kit, separated by SDS-PAGE and subsequently digested with trypsin. Phosphopeptides were enriched employing titanium dioxide, and the obtained fractions were analyzed by nano-LC-MS/MS. A total of 160 phosphoproteins and 328 phosphorylation sites were identified in thymoma cells. Among the differentially phosphorylated proteins identified in TBTO-treated cells were key enzymes, which catalyze rate-limiting steps in pathways that are sensitive to cellular energy status. These proteins included acetyl-CoA carboxylase isoform 1, which catalyzes the rate-limiting step of fatty acid synthesis. Another enzyme was glutamine: fructose-6-phosphate amidotransferase, GFAT1, the first and rate-limiting enzyme for the hexoamine synthesis pathway. Pyruvate dehydrogenase (PDH), a multicomplex enzyme that catalyzes the rate-limiting step of aerobic oxidation of fuel carbohydrates, was identified in both TBTO-treated and control cells; however, phosphorylation at residue S293, known to inhibit PDH activity, was identified only in control cells. A lower expression level of ribosomal protein S6 kinase 1, a downstream kinase of the mammalian target of rapamycin signaling pathway implicated in protein synthesis through phosphorylation of 40 ribosomal S6, was observed in the treated cells. Giant kinases like AMP-activated protein kinase (AMPK) and cAMP-dependent protein kinase (PKAR1A), which are known to mediate the phosphorylation of these enzymes, were identified in TBTO-treated cells. Downregulation of proteins, such as MAPK, matrin-3 and ribonucleotide reductase, subunit RRM2, which are implicated in cell proliferation, was also observed in TBTO-treated cells. Together, the results show that TBTO affects proliferation and energy sensor pathways." @default.
• W2010414831 created "2016-06-24" @default.
• W2010414831 creator A5018860055 @default.
• W2010414831 creator A5034364029 @default.
• W2010414831 date "2011-12-15" @default.
• W2010414831 modified "2023-10-07" @default.
• W2010414831 title "Phosphoproteomic Analysis of Mouse Thymoma Cells Treated With Tributyltin Oxide: TBTO Affects Proliferation and Energy Sensing Pathways" @default.
• W2010414831 cites W1504209518 @default.
• W2010414831 cites W1504251053 @default.
• W2010414831 cites W1536062643 @default.
• W2010414831 cites W1543018730 @default.
• W2010414831 cites W1566946085 @default.
• W2010414831 cites W1965644633 @default.
• W2010414831 cites W1977344910 @default.
• W2010414831 cites W1977436170 @default.
• W2010414831 cites W1978382819 @default.
• W2010414831 cites W1981166080 @default.
• W2010414831 cites W1981180920 @default.
• W2010414831 cites W1981814090 @default.
• W2010414831 cites W1982164601 @default.
• W2010414831 cites W1984736455 @default.
• W2010414831 cites W1986571317 @default.
• W2010414831 cites W1987972127 @default.
• W2010414831 cites W1989137715 @default.
• W2010414831 cites W1991524853 @default.
• W2010414831 cites W2000697370 @default.
• W2010414831 cites W2001790945 @default.
• W2010414831 cites W2009604023 @default.
• W2010414831 cites W2010238890 @default.
• W2010414831 cites W2015700471 @default.
• W2010414831 cites W2028124816 @default.
• W2010414831 cites W2033971720 @default.
• W2010414831 cites W2034121267 @default.
• W2010414831 cites W2034171588 @default.
• W2010414831 cites W2037235997 @default.
• W2010414831 cites W2040001614 @default.
• W2010414831 cites W2042692959 @default.
• W2010414831 cites W2045342330 @default.
• W2010414831 cites W2052081866 @default.
• W2010414831 cites W2052249831 @default.
• W2010414831 cites W2059052337 @default.
• W2010414831 cites W2059572899 @default.
• W2010414831 cites W2060357275 @default.
• W2010414831 cites W2060600856 @default.
• W2010414831 cites W2061202598 @default.
• W2010414831 cites W2063120457 @default.
• W2010414831 cites W2066433170 @default.
• W2010414831 cites W2069590842 @default.
• W2010414831 cites W2073451122 @default.
• W2010414831 cites W2077638177 @default.
• W2010414831 cites W2077645437 @default.
• W2010414831 cites W2077795832 @default.
• W2010414831 cites W2081254567 @default.
• W2010414831 cites W2085351745 @default.
• W2010414831 cites W2085471749 @default.
• W2010414831 cites W2088411366 @default.
• W2010414831 cites W2101133609 @default.
• W2010414831 cites W2127007481 @default.
• W2010414831 cites W2129585918 @default.
• W2010414831 cites W2135009984 @default.
• W2010414831 cites W2165923048 @default.
• W2010414831 cites W2337551426 @default.
• W2010414831 cites W2740796197 @default.
• W2010414831 cites W4293247451 @default.
• W2010414831 doi "https://doi.org/10.1093/toxsci/kfr333" @default.
• W2010414831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22174045" @default.
• W2010414831 hasPublicationYear "2011" @default.
• W2010414831 type Work @default.
• W2010414831 sameAs 2010414831 @default.
• W2010414831 citedByCount "15" @default.
• W2010414831 countsByYear W20104148312012 @default.
• W2010414831 countsByYear W20104148312013 @default.
• W2010414831 countsByYear W20104148312014 @default.
• W2010414831 countsByYear W20104148312015 @default.
• W2010414831 countsByYear W20104148312019 @default.
• W2010414831 countsByYear W20104148312021 @default.
• W2010414831 countsByYear W20104148312022 @default.
• W2010414831 crossrefType "journal-article" @default.
• W2010414831 hasAuthorship W2010414831A5018860055 @default.
• W2010414831 hasAuthorship W2010414831A5034364029 @default.
• W2010414831 hasBestOaLocation W20104148311 @default.
• W2010414831 hasConcept C104202773 @default.
• W2010414831 hasConcept C11960822 @default.
• W2010414831 hasConcept C184235292 @default.
• W2010414831 hasConcept C185592680 @default.
• W2010414831 hasConcept C2780926556 @default.
• W2010414831 hasConcept C55493867 @default.
• W2010414831 hasConcept C75217442 @default.
• W2010414831 hasConcept C86803240 @default.
• W2010414831 hasConcept C87325107 @default.
• W2010414831 hasConcept C97029542 @default.
• W2010414831 hasConceptScore W2010414831C104202773 @default.
• W2010414831 hasConceptScore W2010414831C11960822 @default.
• W2010414831 hasConceptScore W2010414831C184235292 @default.
• W2010414831 hasConceptScore W2010414831C185592680 @default.
• W2010414831 hasConceptScore W2010414831C2780926556 @default.
• W2010414831 hasConceptScore W2010414831C55493867 @default.
• W2010414831 hasConceptScore W2010414831C75217442 @default.

• next